rss
Thorax 2008;63:67-71 doi:10.1136/thx.2007.078857
  • Tuberculosis

Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis

  1. R A M Breen1,2,
  2. S M Barry1,2,
  3. C J Smith3,
  4. R J Shorten4,
  5. J P Dilworth2,
  6. I Cropley2,
  7. T D McHugh4,
  8. S H Gillespie4,
  9. G Janossy1,
  10. M C I Lipman2
  1. 1
    Department of Immunology, Royal Free and University College Medical School, London, UK
  2. 2
    Departments of Thoracic and HIV Medicine, Royal Free Hospital, London, UK
  3. 3
    Department of Primary Care and Population Science, Royal Free and University College Medical School, London, UK
  4. 4
    Centre for Medical Microbiology, Royal Free and University College Medical School, London, UK
  1. Dr R A M Breen, Department of Thoracic and HIV Medicine, Royal Free Hospital, London NW3 2QG, UK; r.breen{at}doctors.org.uk
  • Revised 25 June 2007
  • Accepted 27 June 2007
  • Published Online First 3 August 2007

Abstract

Background: Immunological ex vivo assays to diagnose tuberculosis (TB) have great potential but have largely been blood-based and poorly evaluated in active TB. Lung sampling enables combined microbiological and immunological testing and uses higher frequency antigen-specific responses than in blood.

Methods: A prospective evaluation was undertaken of a flow cytometric assay measuring the percentage of interferon-γ synthetic CD4+ lymphocytes following stimulation with purified protein derivative of Mycobacterium tuberculosis (PPD) in bronchoalveolar lavage fluid from 250 sputum smear-negative individuals with possible TB. A positive assay was defined as >1.5%.

Results: Of those who underwent lavage and were diagnosed with active TB, 95% (106/111) had a positive immunoassay (95% CI 89% to 98%). In 139 individuals deemed not to have active TB, 105 (76%) were immunoassay negative (95% CI 68% to 82%). Of the remaining 24% (34 cases) with a positive immunoassay, a substantial proportion had evidence of untreated TB; in two of these active TB was subsequently diagnosed. Assay performance was unaffected by HIV status, disease site or BCG vaccination. In culture-positive pulmonary cases, response to PPD was more sensitive than nucleic acid amplification testing (94% vs 73%). The use of early secretory antigen target-6 (ESAT-6) responses in 71 subjects was no better than PPD, and 19% of those with culture-confirmed TB and a positive PPD immunoassay had no detectable response to ESAT-6.

Conclusions: These findings suggest that lung-orientated immunological investigation is a potentially powerful tool in diagnosing individuals with sputum smear-negative active TB, regardless of HIV serostatus.

Footnotes

  • Funding: None

  • Competing interests: None

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. thx.2007.078857v1
    2. 63/1/67 most recent

Services

  1. Email this link to a friend
  2. Alert me when this article is cited
  3. Alert me if a correction is posted
  4. Article Usage Statistics
  5. Similar articles in this journal
  6. Similar articles in Web of Science
  7. Similar articles in PubMed
  8. Add article to my folders
  9. Download to citation manager
  10. Request permissions

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Free archive
The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.